Europe Pharmaceutical Gelatin Market was worth USD xx billion in 2018 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2023. Pharmaceutical gelatin is colourless and a delicate substance with a high molecular weight. It is used in pharmaceutical industries owing to its absorbable nature. It is used to maintain the stability of pharmaceutical suspensions and serves as a substitute for plasma.
Growing nutraceutical and pharmaceutical industries are driving the market growth. Rising aging population coupled with increased awareness about nutritional food is further propelling the market growth. However, presence of alternatives and the high cost of gelatin are the major market restraints.
The market for Pharmaceutical Gelatin is broadly categorized into function, source and application. By function the market is segmented into stabilizers, thickeners, gelling agents and others. By source the market is classified into pig skin, bovine hides, bones and others. By application the market is divided into hard capsules, soft capsules, microencapsulation, coating and absorbable haemostat. On the basis of geography, the market is analysed under various regions namely U.K , Italy, France, Spain and Germany. The Pharmaceutical Gelatin market was dominated by Europe.
Some of the major companies dominating the market, by their products and services include Rousselot, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Tessenderlo Group, Sterling Gelatin, Roxlor llc, Weishardt, and Gelita AG.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Function
5.1.1 Introduction
5.1.2 Stabilizers
5.1.3 Thickeners
5.1.4 Gelling agents
5.1.5 Y-o-Y Growth Analysis, By function
5.1.6 Market Attractiveness Analysis, By function
5.1.7 Market Share Analysis, By function
5.2 Source
5.2.1 Introduction
5.2.2 Pig skin
5.2.3 Bovine hides
5.2.4 Bones
5.2.5 Y-o-Y Growth Analysis, By source
5.2.6 Market Attractiveness Analysis, By source
5.2.7 Market Share Analysis, By source
5.3 Application
5.3.1 Introduction
5.3.2 Hard capsules
5.3.3 Soft capsules
5.3.4 Micro encapsulation
5.3.5 Coating
5.3.6 Absorbable hemostat
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By function
6.1.3.3 By source
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By function
6.1.4.3 By source
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By function
6.1.5.3 By source
6.1.5.4 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Rousselot
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Tessenderlo Group
8.3 Nitta Gelatin Inc.
8.4 Capsugel
8.5 Catelent Inc.
8.6 Norland Products Inc
8.7 Sterling Gelatin
8.8 Weishardt
8.9 Gelita AG
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
